Drug screening of hair by liquid chromatography-tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 32, Issue 5, 2008, Pages 364-372

  Hegstad, S ^a   Khiabani, H Z ^a   Kristoffersen, L ^a   Kunoe N ^b   Lobmaier, P P ^b   Christophersen, A S ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 7 AMINO 1,3 DIHYDRO 5 PHENYL 2H 1,4 BENZODIAZEPIN 2 ONE; 7 AMINOCLONAZEPAM; 7 AMINOFLUNITRAZEPAM; ACETONITRILE; ALPRAZOLAM; AMPHETAMINE; BENZOYLECGONINE; BUPRENORPHINE; CARISOPRODOL; COCAINE; CODEINE; COTININE; DIAZEPAM; DRUG METABOLITE; ILLICIT DRUG; MEPROBAMATE; METHADONE; METHAMPHETAMINE; MORPHINE; MORPHINE 6 ACETATE; NICOTINE; OXAZEPAM; ZOLPIDEM; ZOPICLONE;

ACCURACY; ARTICLE; DRUG EXPOSURE; DRUG SCREENING; HAIR ANALYSIS; HUMAN; LIQUID CHROMATOGRAPHY; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 45849090293     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.5.364     Document Type: Article

References (29)

1. R. Kronstrand and K. Scott. Drug incorporation into hair. In Analytical and Practical Aspects of Drug Testing in Hair. P. Kintz, Ed. CRC Press, Boca Raton, FL, 2007, pp 1-23.
2. F. Pragst, M. Rothe, K. Spiegel, and F. Sporkert. Illegal and therapeutic drug concentration in hair segments-a timetable of drug exposure. Forensic Sci. Rev. 10: 81-111 (1998).
3. L. Potsch, G. Skopp, and M.R. Moeller. Biochemical approach on the conservation of drug molecules during hair fiber formation. Forensic Sci. Int. 84: 25-35 (1997).
4. G.L. Henderson. Mechanisms of drug incorporation into hair. Forensic Sci. Int. 63: 19-29 (1993).
5. M. Villain, V. Cirimele, and P. Kintz. Hair analysis in toxicology. Clin. Chem. Lab. Med. 42: 1265-1272 (2004).
6. P. Kintz. Value of hair analysis in postmortem toxicology. Forensic Sci. Int. 142: 127-134 (2004).
7. P. Kintz, M. Villain, and V. Cirimele. Hair analysis for drug detection. Ther. Drug Monit. 28: 442-446 (2006).
8. J. Ropero-Miller. A decade revisited-the forensic and clinical applications of hair testing. Forensic Sci. Rev. 19: 50-67 (7 A.D.).
9. P. Kintz, M. Villain, M. Cheze, and G. Pepin. Identification of alprazolam in hair in two cases of drug-facilitated incidents. Forensic Sci. Int. 153: 222-226 (2005).
10. P. Kintz, M. Villain, V. Dumestre-Toulet, and B. Ludes. Drug-facilitated sexual assault and analytical toxicology: the role of LC-MS-MS. A case involving zolpidem. J. Clin. Forensic Med. 12: 36-41 (2005).
11. M. Cheze, M. Villain, and G. Pepin. Determination of bromazepam, clonazepam and metabolites after a single intake in urine and hair by LC-MS-MS. Application to forensic cases of drug facilitated crimes. Forensic Sci. Int. 145: 123-130 (2004).
12. M. Cheze, G. Duffort, M. Deveaux, and G. Pepin. Hair analysis by liquid chromatography-tandem mass spectrometry in toxicological investigation of drug-facilitated crimes: report of 128 cases over the period June 2003-May 2004 in metropolitan Paris. Forensic Sci. Int. 153: 3-10 (2005).
13. J.H. Beumer, I.J. Bosman, and R.A. Maes. Hair as a biological specimen for therapeutic drug monitoring. Int. J. Clin. Pract. 55: 353-357 (2001).
14. H. Druid, J.J. Strandberg, K. Alkass, I. Nystrom, F.C. Kugelberg, and R. Kronstrand. Evaluation of the role of abstinence in heroin overdose deaths using segmental hair analysis. Forensic Sci. Int. 168: 223-226 (2007).
15. M.R. Moeller, H. Sachs, and F. Pragst. Application of hair in driving-license regranting. In Analytical and Practical Aspects of Drug Testing in Hair, P. Kintz, Ed. CRC Press, Boca Raton, FL, 2007, pp 273-285.
16. T. Cairns, V. Hill, M. Schaffer, and W. Thistle. Amphetamines in washed hair of demonstrated users and workplace subjects. Forensic Sci. Int. 145: 137-142 (2004).
17. T. Cairns, V. Hill, M. Schaffer, and W. Thistle. Levels of cocaine and its metabolites in washed hair of demonstrated cocaine users and workplace subjects. Forensic Sci. Int. 145: 175-181 (2004).
18. F. Tagliaro, R. Valentini, G. Manetto, F. Crivellente, G. Carli, and M. Marigo. Hair analysis by using radioimmunoassay, high-performance liquid chromatography and capillary electrophoresis to investigate chronic exposure to heroin, cocaine and/or ecstasy in applicants for driving licences. Forensic Sci. Int. 107: 121-128 (2000).
19. A. Negrusz, C. Moore, D. Deitermann, D. Lewis, K. Kaleciak, R. Kronstrand, B. Feeley, and R.S. Niedbala. Highly sensitive micro-plate enzyme immunoassay screening and NCI-GC-MS confirmation of flunitrazepam and its major metabolite 7-aminoflunitrazepam in hair. J. Anal. Toxicol. 23: 429-435 (1999).
20. S. Paterson, N. McLachlan-Troup, R. Cordero, M. Dohnal, and S. Carman. Qualitative screening for drugs of abuse in hair using GC-MS. J. Anal. Toxicol. 25: 203-208 (2001).
21. V. Cirimele, P. Kintz, and B. Ludes. Screening for forensically relevant benzodiazepines in human hair by gas chromatography-negative ion chemical ionization-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 700: 119-129 (1997).
22. R. Kronstrand, I. Nystrom, J. Strandberg, and H. Druid. Screening for drugs of abuse in hair with ion spray LC-MS-MS. Forensic Sci. Int. 145: 183-190 (2004).
23. M. Villain, M. Concheiro, V. Cirimele, and P. Kintz. Screening method for benzodiazepines and hypnotics in hair at pg/mg level by liquid chromatography-mass spectrometry-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825: 72-78 (2005).
24. H.H. Maurer. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS-MS) relevant to clinical and forensic toxicology. Clin. Biochem. 38: 310-318 (2005).
25. G.K. Hulse, D.E. Arnold-Reed, G. O'Neil, C.T. Chan, and R.C. Hansson. Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants. Addict. Biol. 9: 67-72 (2004).
26. H. Waal, G. Frogopsahl, L. Olsen, A. S. Christophersen, and J. Morland. Naltrexone implants-duration, tolerability and clinical usefulness. A pilot study. Eur. Addict Res. 12: 138-144 (2006).
27. S.D. Comer, M.A. Sullivan, E. Yu, J.L. Rothenberg, H.D. Kleber, K. Kampman, C. Dackis, and C.P. O'Brien. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry 63: 210-218 (2006).
28. www.clinicaltrial.gov/ct2/show/NCT00269607?term=naltrexone+oslo&rank= 3, December 2005.
29. B.K. Matuszewski, M.L. Constanzer, and C.M. Chavez-Eng. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS-MS. Anal. Chem. 75: 3019-3030 (2003).